Incidence of Non-AIDS-Defining Malignancies in HIV-Infected Vs. Non-Infected Patients in the HAART Era: Impact of Immunosuppression

Por Bedimo, Roger J., McGinnis, Kathleen A., Dunlap, Melinda, Rodriguez-Barradas, Maria C., Justice, Amy C.
Publicado em 2009

Does HAART efficacy translate to effectiveness? Evidence for a trial effect.

Por Prema Menezes, William C Miller, David A Wohl, Adaora A Adimora, Peter A Leone, William C Miller, Joseph J Eron
Publicado em 2011-01-01

Does HAART Efficacy Translate to Effectiveness? Evidence for a Trial Effect

Por Menezes, Prema, Miller, William C., Wohl, David A., Adimora, Adaora A., Leone, Peter A., Miller, William C., Eron, Joseph J.
Publicado em 2011

Specific prebiotics modulate gut microbiota and immune activation in HAART-naive HIV-infected adults: results of the “COPA” pilot randomized trial

Por Gori, A, Rizzardini, G, van't Land, B, Amor, K B, van Schaik, J, Torti, C, Quirino, T, Tincati, C, Bandera, A, Knol, J, Benlhassan-Chahour, K, Trabattoni, D, Bray, D, Vriesema, A, Welling, G, Garssen, J, Clerici, M
Publicado em 2011

Self-Perception of Body Fat Changes and HAART Adherence in the Women’s Interagency HIV Study

Por Plankey, Michael, Bacchetti, Peter, Jin, Chengshi, Grimes, Barbara, Hyman, Charles, Cohen, Mardge, Howard, Andrea A., Tien, Phyllis C.
Publicado em 2008

Changes in clearance, volume and bioavailability of immunosuppressants when given with HAART in HIV-1 infected liver and kidney transplant recipients

Por Frassetto, L.A., Floren, L.C., Barin, B., Browne, M., Wolfe, A.R., Roland, M.E., Stock, P.G., Carlson, L., Christians, U., Benet, L.Z.
Publicado em 2013

Does HIV adversely influence the outcome in advanced non-small-cell lung cancer in the era of HAART?

Por Powles, T, Thirwell, C, Newsom-Davis, T, Nelson, M, Shah, P, Cox, S, Gazzard, B, Bower, M
Publicado em 2003

Increase in Non-AIDS Related Conditions as Causes of Death among HIV-Infected Individuals in the HAART Era in Brazil

Por Pacheco, Antonio G., Tuboi, Suely H., Faulhaber, José C., Harrison, Lee H., Schechter, Mauro
Publicado em 2008

Inferiority of IL-2 alone versus IL-2 plus HAART in maintaining CD4 T cell counts during HAART interruption: a randomized controlled trial

Por Porter, Brian O., Anthony, Kara B., Shen, Jean, Hahn, Barbara, Keh, Chris E., Maldarelli, Frank, Blackwelder, William C., Lane, H. Clifford, Kovacs, Joseph A., Davey, Richard T., Sereti, Irini
Publicado no AIDS (2009)

Virologic outcomes of HAART with concurrent use of cytochrome P450 enzyme-inducing antiepileptics: a retrospective case control study

Por Okulicz, Jason F, Grandits, Greg A, French, Jacqueline A, George, Jomy M, Simpson, David M, Birbeck, Gretchen L, Ganesan, Anuradha, Weintrob, Amy C, Crum-Cianflone, Nancy, Lalani, Tahaniyat, Landrum, Michael L
Publicado em 2011

Impact of NNRTI compared to PI-based highly active antiretroviral therapy on CCR5 receptor expression, β-chemokines and IL-16 secretion in HIV-1 infection

Por Burton, C T, Hardy, G A D, Sullivan, A K, Nelson, M R, Gazzard, B, Gotch, F M, Imami, N
Publicado em 2002

The Impact of HAART on the Respiratory Complications of HIV Infection: Longitudinal Trends in the MACS and WIHS Cohorts

Por Gingo, Matthew R., Balasubramani, G. K., Kingsley, Lawrence, Rinaldo, Charles R., Alden, Christine B., Detels, Roger, Greenblatt, Ruth M., Hessol, Nancy A., Holman, Susan, Huang, Laurence, Kleerup, Eric C., Phair, John, Sutton, Sarah H., Seaberg, Eric C., Margolick, Joseph B., Wisniewski, Stephen R., Morris, Alison
Publicado em 2013

Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study

Por Franceschi, S, Lise, M, Clifford, G M, Rickenbach, M, Levi, F, Maspoli, M, Bouchardy, C, Dehler, S, Jundt, G, Ess, S, Bordoni, A, Konzelmann, I, Frick, H, Dal Maso, L, Elzi, L, Furrer, H, Calmy, A, Cavassini, M, Ledergerber, B, Keiser, O
Publicado em 2010

The Innate Immune Response in HIV/AIDS Septic Shock Patients: A Comparative Study

Por Amancio, Rodrigo T., Japiassu, Andre M., Gomes, Rachel N., Mesquita, Emersom C., Assis, Edson F., Medeiros, Denise M., Grinsztejn, Beatriz, Bozza, Patrícia T., Castro-Faria, Hugo C., Bozza, Fernando A.
Publicado em 2013

PRE-EXISTING ALBUMINURIA PREDICTS AIDS AND NON-AIDS MORTALITY IN WOMEN INITIATING ANTIRETROVIRAL THERAPY

Por Wyatt, Christina M., Hoover, Donald R., Shi, Qiuhu, Tien, Phyllis C., Karim, Roksana, Cohen, Mardge H., Goderre, Johanna L., Seaberg, Eric C., Lazar, Jason, Young, Mary A., Klotman, Paul E., Anastos, Kathryn
Publicado em 2011

IL-10 mediated by herpes simplex virus vector reduces neuropathic pain induced by HIV gp120 combined with ddC in rats

Por Zheng, Wenwen, Huang, Wan, Liu, Shue, Levitt, Roy C, Candiotti, Keith A, Lubarsky, David A, Hao, Shuanglin
Publicado em 2014

Hepatitis B and long-term HIV outcomes in co-infected HAART recipients

Por Hoffmann, Christopher J, Seaberg, Eric C, Young, Stephen, Witt, Mallory D, D’Acunto, Kristin, Phair, John, Thio, Chloe L
Publicado em 2009

Impact of the human immunodeficiency virus on early multidrug-resistant tuberculosis treatment outcomes in Botswana

Por Hafkin, J., Modongo, C., Newcomb, C., Lowenthal, E., MacGregor, R. R., Steenhoff, A. P., Friedman, H., Bisson, G. P.
Publicado no Int J Tuberc Lung Dis (2013)

Plasma Mitochondrial DNA Levels as a Biomarker of Lipodystrophy Among HIV-Infected Patients Treated with Highly Active Antiretroviral Therapy (HAART)

Por Dai, Z., Cai, W., Hu, F., Lan, Y., Li, L., Chung, C., Caughey, B., Zhang, K., Tang, X.
Publicado no Curr Mol Med (2015)

HIV DNA and cognition in a Thai longitudinal HAART initiation cohort: The SEARCH 001 Cohort Study

Por Valcour, V G., Shiramizu, B T., Sithinamsuwan, P, Nidhinandana, S, Ratto-Kim, S, Ananworanich, J, Siangphoe, U, Kim, J H., de Souza, M, Degruttola, V, Paul, R H., Shikuma, C M.
Publicado em 2009